Michelle Yang

Company: OBI Pharma

Job title: Director, Head of PMO

Seminars:

Panel Discussion: Streamlining Regulatory Approaches to Optimize CDx Development, Reduce Complexities & Allow Patients Timely Access to Drug-Diagnostics Clinical Trials 9:30 am

Given the fragmentation of regulatory requirements, will it be more beneficial to stakeholders to harmonise across APAC or will this create friction? Is there a future for there to be one solution that covers all regions to increase harmonisation and enable broader knowledge sharing between countries? Understanding different registration requirements across the region to increase…Read more

day: Conference Day 2

Translating Biomarker Studies from Pre-Clinical to Clinical Development 4:15 pm

Identifying clinically meaningful biomarkers that impact the design of studies at different development stages Interpreting biomarker study results – key considerations Patient selection – Are there options other than CDx development?Read more

day: Conference Day 2